301 related articles for article (PubMed ID: 1361306)
1. Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labeling and DNA flow cytometry data.
Fontanini G; Pingitore R; Bigini D; Vignati S; Pepe S; Ruggiero A; Macchiarini P
Am J Pathol; 1992 Dec; 141(6):1285-90. PubMed ID: 1361306
[TBL] [Abstract][Full Text] [Related]
2. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
Yu CC; Dublin EA; Camplejohn RS; Levison DA
Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
[TBL] [Abstract][Full Text] [Related]
3. Relationship between apoptosis and immunohistochemical staining for proliferating cell nuclear antigen and Ki-67 in non-small cell lung cancer.
Ishiwata N; Jinn Y; Tsukada Y; Inase N; Ichioka M; Yoshizawa Y
Anticancer Res; 2000; 20(3A):1445-50. PubMed ID: 10928055
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between cellular DNA contents and cell proliferation of non-small cell lung cancer estimated by simultaneous quantification of PCNA and DNA contents by flow cytometer].
Morita K; Hayashi Y; Nagao S; Watanabe Y
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():164-7. PubMed ID: 7611782
[TBL] [Abstract][Full Text] [Related]
5. The proliferative fraction in lymph nodes: a comparison of proliferating cell nuclear antigen morphometry to flow cytometry.
Krauss JS; Pantazis CG; Chandler FW
Ann Clin Lab Sci; 1992; 22(3):189-96. PubMed ID: 1354428
[TBL] [Abstract][Full Text] [Related]
6. Ki-67 labeling indices in non-small cell lung cancer: comparison between image cytometry and flow cytometry.
Ishikuro A; Dosaka-Akita H; Kato M; Fujino M; Isobe H; Miyamoto H; Inoue K; Kawakami Y
Cytometry; 1997 Aug; 30(4):186-91. PubMed ID: 9298837
[TBL] [Abstract][Full Text] [Related]
7. Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms.
Steck K; el-Naggar AK
Cytometry; 1994 Nov; 17(3):258-65. PubMed ID: 7851161
[TBL] [Abstract][Full Text] [Related]
8. A technique for automatic/interactive assessment of the proliferating fraction of neoplastic cells in solid tumors. A methodological study on the Ki-67 immunoreactive cells in human mammary carcinomas, including a comparison with the results of conventional S-phase fraction assessments by means of DNA cytometry.
Parrado C; Falkmer UG; Höög A; Falkmer S; Ahrens O; Rius F; Grimelius L
Gen Diagn Pathol; 1996 Mar; 141(3-4):215-27. PubMed ID: 8705786
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.
Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET
Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573
[TBL] [Abstract][Full Text] [Related]
10. The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node-negative non-small cell lung cancer.
Fontanini G; Macchiarini P; Pepe S; Ruggiero A; Hardin M; Bigini D; Vignati S; Pingitore R; Angeletti CA
Cancer; 1992 Sep; 70(6):1520-7. PubMed ID: 1355398
[TBL] [Abstract][Full Text] [Related]
11. PCNA/cyclin expression in transitional cell carcinomas of the human bladder: its correlation with Ki-67 and epidermal growth factor receptor immunostainings.
Serio G
Pathologica; 1994 Apr; 86(2):161-6. PubMed ID: 7936759
[TBL] [Abstract][Full Text] [Related]
12. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.
Khine MM; Aung W; Sibbons PD; Howard CV; Clapham E; McGill F; Van Velzen D
Lab Invest; 1994 Jan; 70(1):125-9. PubMed ID: 7905542
[TBL] [Abstract][Full Text] [Related]
13. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
Tanioka F; Hiroi M; Yamane T; Hara H
Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms.
Goldblum JR; Shannon R; Kaldjian EP; Thiny M; Davenport R; Thompson N; Lloyd RV
Mod Pathol; 1993 Nov; 6(6):663-8. PubMed ID: 7508113
[TBL] [Abstract][Full Text] [Related]
15. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.
Siitonen SM; Kallioniemi OP; Isola JJ
Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759
[TBL] [Abstract][Full Text] [Related]
16. Proliferating cell nuclear antigen in archival surgical specimens of malignant lymphoma and metastatic carcinoma: immunohistochemical and flow cytometric analysis.
Gorczyca W; Kram A; Tuziak T; Darzynkiewicz Z; Melamed MR
Patol Pol; 1993; 44(3):121-8. PubMed ID: 7902557
[TBL] [Abstract][Full Text] [Related]
17. A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction.
Nordström B; Strang P; Bergström R; Nilsson S; Tribukait B
Cancer; 1996 Nov; 78(9):1942-51. PubMed ID: 8909315
[TBL] [Abstract][Full Text] [Related]
18. DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas.
Czader M; Porwit A; Tani E; Ost A; Mazur J; Auer G
Mod Pathol; 1995 Jan; 8(1):51-8. PubMed ID: 7731942
[TBL] [Abstract][Full Text] [Related]
19. Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer.
Yoshimatsu T; Uramoto H; Oyama T; Yashima Y; Gu C; Morita M; Sugio K; Kohno K; Yasumoto K
Anticancer Res; 2005; 25(5):3437-43. PubMed ID: 16101161
[TBL] [Abstract][Full Text] [Related]
20. p53 expression in non small cell lung cancer: clinical and biological correlations.
Fontanini G; Bigini D; Vignati S; Macchiarini P; Pepe S; Angeletti CA; Pingitore R; Squartini F
Anticancer Res; 1993; 13(3):737-42. PubMed ID: 8100413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
